Links:

• 'Disturbing': Experts troubled by Canada’s euthanasia laws | AP News — Canada’s road to allowing euthanasia began in 2015, when its highest court declared that outlawing assisted suicide deprived people of their dignity and autonomy. It gave national leaders a year to draft legislation. The resulting 2016 law legalized both euthanasia and assisted suicide for people aged 18 and over provided they met certain conditions: They had to have a serious condition, disease or disability that was in an advanced, irreversible state of decline and enduring “unbearable physical or mental suffering that cannot be relieved under conditions that patients consider acceptable.” Their death also had to be “reasonably foreseeable,” and the request for euthanasia had to be approved by at least two physicians. The law was later amended to allow people who are not terminally ill to choose death, significantly broadening the number of eligible people. Critics say that change removed a key safeguard aimed at protecting people with potentially years or decades of life left.
• Alec MacGillis on Twitter — Have often wondered the same thing as Janan Ganesh
• The vibes theory of politics | Financial Times — For a sense of how little I believe in belief, here is an experiment that I have been running in my head for two years. Imagine, at the start of the pandemic, that Donald Trump had shut his country down and Angela Merkel had kept hers open. He justified his action as a protector of the homeland while she stressed liberal ideals. (“As a girl in East Germany, I saw the human cost of draconian . . . ”)

Links:

• The BA.5 story - by Eric Topol - Ground Truths — The Omicron sub-variant BA.5 is the worst version of the virus that we’ve seen. It takes immune escape, already extensive, to the next level, and, as a function of that, enhanced transmissibility, well beyond Omicron (BA.1) and other Omicron family variants that we’ve seen (including BA.1.1, BA.2, BA.2.12.1, and BA.4). You could say it’s not so bad because there hasn’t been a marked rise in hospitalizations and deaths as we saw with Omicron, but that’s only because we had such a striking adverse impact from Omicron, for which there is at least some cross-immunity (BA.1 to BA.5). Here I will review (1) what we know about its biology; (2) its current status around the world; and (3) the ways we can defend against it.
• The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care: Topol MD, Eric: 9780465061839: Amazon.com: Books — How genomics, big data, and digital technology are revolutionizing every aspect of medicine, from physical exams to drug prescriptions to organ transplants
• Small Study on Rectal Cancer Results in Remission in Every Patient - The New York Times — The study was small, and experts say it needs to be replicated. But for 18 people with rectal cancer, the outcome led to “happy tears.”
• Milošev blog – Ne, dostarlimab nije čudesni lek protiv raka koji može da izleči svakoga — Svakih par godina, priča o o revolucionarnoj novoj studiji koja je pronašla lek protiv raka počne da kruži svim svetskim medijima, pa i srpskim. Pre četiri godine to je bila priča sa Stanforda koja je dobre rezultate na miševima predstavila kao nekakvo epohalno otkriće. To je bio tipičan primer nenamernog širenja zdravstvenih dezinformacija kao posledica lošeg prevoda i nepoznavanja konteksta. Najnovija priča je malo drugačija.
• Inside the Virus-Hunting Nonprofit at the Center of the Lab-Leak Controversy | Vanity Fair — Chasing scientific renown, grant dollars, and approval from Dr. Anthony Fauci, Peter Daszak transformed the environmental nonprofit EcoHealth Alliance into a government-funded sponsor of risky, cutting-edge virus research in both the U.S. and Wuhan, China. Drawing on more than 100,000 leaked documents, a V.F. investigation shows how an organization dedicated to preventing the next pandemic found itself suspected of helping start one.
• Amazon.com: Bottle of Lies: The Inside Story of the Generic Drug Boom: 9780062338785: Eban, Katherine: Books — Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true?

Links:

• Coronavirus chart: see how your country compares | Free to read | Financial Times — Governments’ stark daily figures on the spread of coronavirus are difficult to compare across countries, and may be significant undercounts. But the data needed to analyse the more reliable and comparable excess mortality metric are only available in a few jurisdictions, leaving these official case and death counts the best available data for much of the world.
• What we know about Omicron variant that has sparked global alarm | Financial Times — Studies show emerging strain is more transmissible and has higher resistance to vaccines
• Webinar April 27, 2021 - Johnson & Johnson/Janssen COVID-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome (TTS): Update for Clinicians — This COCA Call will present the latest evidence on thrombosis with thrombocytopenia syndrome (TTS) after administration of the Johnson & Johnson/Janssen COVID-19 vaccine. Speakers will discuss information on TTS and updated vaccine recommendations.
• Clinical Considerations: Myocarditis after mRNA COVID-19 Vaccines | CDC — Since April 2021, increased cases of myocarditis and pericarditis have been reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna), particularly in adolescents and young adults. There has not been a similar reporting pattern observed after receipt of the Janssen COVID-19 Vaccine (Johnson & Johnson).

• Lično mišljenje, ne medicinski savet. Pre donošenja zravstvenih odluka konsultujte se sa svojim lekarom.

Links:

• FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 Vaccine for Certain Populations | FDA — Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for use of a single booster dose, to be administered at least six months after completion of the primary series in: individuals 65 years of age and older; individuals 18 through 64 years of age at high risk of severe COVID-19; and individuals 18 through 64 years of age whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19 including severe COVID-19. Today’s authorization applies only to the Pfizer-BioNTech COVID-19 Vaccine.

Links:

• George Carlin - Idiot and Maniac - YouTube